C12Y 301/21003
Type i site-specific deoxyribonuclease
Official title: Type I site-specific deoxyribonuclease (3.1.21.3)
C12Y301/21003 (Type i site-specific deoxyribonuclease) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 7
- Assignees
- 7
- Inventors
- 13
- Latest grant
- 5 Nov 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Integrated system for programmable DNA methylation5 Nov 2019US 10,465,187 B2Trustees of Boston University
- Method for treating oncological diseases19 Dec 2017US 9,845,461 B2CLS Therapeutics Limited
- Method for treating oncological diseases2 Feb 2016US 9,248,166 B2CLS Therapeutics Limited
- Method for treating oncological diseases29 Apr 2014US 8,710,012 B2CLS Therapeutics Limited
- CRISPR-Cas Effector Polypeptides, Lipid Nanoparticles, and Methods of Use Thereof2 Jul 2026US 2026/0185070 A1The Regents of the University of California
- Integrated system for programmable dna methylation30 Aug 2018US 2018/0245075 A1Trustees of Boston University
- Methods and pharmaceutical compositions for treating vaso-occlusive crisis23 Feb 2017US 2017/0049862 A1Assistance Publique-HôPitaux De Paris (Aphp)
- Method for treating oncological diseases12 May 2016US 2016/0130570 A1CLS Therapeutics Limited
- Method for treating oncological diseases10 Jul 2014US 2014/0193389 A1CLS Therapeutics Limited
Most cited
By later US patents